ATE279198T1 - Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung - Google Patents

Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Info

Publication number
ATE279198T1
ATE279198T1 AT98942166T AT98942166T ATE279198T1 AT E279198 T1 ATE279198 T1 AT E279198T1 AT 98942166 T AT98942166 T AT 98942166T AT 98942166 T AT98942166 T AT 98942166T AT E279198 T1 ATE279198 T1 AT E279198T1
Authority
AT
Austria
Prior art keywords
endometrum
progestagens
oral contraception
spareing
atrophizing
Prior art date
Application number
AT98942166T
Other languages
English (en)
Inventor
Michael Kafrissen
Haya Taitel
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE279198T1 publication Critical patent/ATE279198T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
AT98942166T 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung ATE279198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (1)

Publication Number Publication Date
ATE279198T1 true ATE279198T1 (de) 2004-10-15

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942166T ATE279198T1 (de) 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Country Status (9)

Country Link
EP (1) EP1007052B1 (de)
JP (1) JP2001513566A (de)
AT (1) ATE279198T1 (de)
AU (1) AU9028098A (de)
DE (1) DE69827017T2 (de)
DK (1) DK1007052T3 (de)
ES (1) ES2230711T3 (de)
PT (1) PT1007052E (de)
WO (1) WO1999009993A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
BRPI0412493A (pt) * 2003-07-16 2006-10-17 Duramed Pharmaceuticals Inc métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
US20050090475A1 (en) * 2003-10-01 2005-04-28 Laguardia Katherine D. Extended triphasic contraceptive regimens
EP1535618A1 (de) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmazeutische Zubereitung zur kontinuierlichen hormonellen Behandlung über einen Zeitraum von über 21-28 Tage beinhaltend zwei Estrogen und/oder Progestin Zusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
ATE209919T1 (de) * 1987-09-24 2001-12-15 Jencap Res Ltd Oestrogen und progestin enthaltende verhütungspackungen
DE4104385C1 (de) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DK1007052T3 (da) 2005-01-31
PT1007052E (pt) 2005-01-31
DE69827017D1 (de) 2004-11-18
AU9028098A (en) 1999-03-16
ES2230711T3 (es) 2005-05-01
DE69827017T2 (de) 2006-03-09
EP1007052B1 (de) 2004-10-13
WO1999009993A1 (en) 1999-03-04
JP2001513566A (ja) 2001-09-04
EP1007052A1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
GT199800126A (es) Terapia de combinacion.
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
ES2132645T3 (es) Uso en una composicion farmaceutica.
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
FI950774A (fi) Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon
KR970704430A (ko) 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
TR199700930T2 (xx) Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit.
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
NO986104D0 (no) Progesteron-anti-progesteron regimer
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE69932510D1 (de) Vaskularisierungsinhibitoren
ATE304359T1 (de) Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
NO20004419D0 (no) Ny anvendelse
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
AU1518902A (en) Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
ES2079687T3 (es) Composicion topica.
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
DE69631770D1 (de) Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort
ES2152315T3 (es) Xamoneline tartrato.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007052

Country of ref document: EP